A. Maksimenko

发表

Thrombolysis strategy: Joint action of plasminogen activators. Thrombolytic compositions (A review)

A. Maksimenko, E. G. Tishchenko, 1998, Pharmaceutical Chemistry Journal.

New Thrombolytic Strategy: Bolus Administration of tPA and Urokinase-Fibrinogen Conjugate

A. Maksimenko, E. Tischenko, 1999, Journal of Thrombosis and Thrombolysis.

New Strategy of Thrombolysis: Conjunctive Effect of Plasminogen Activators with Different Pharmacokinetic Profile a

A. Maksimenko, 1998, Annals of the New York Academy of Sciences.

In vitro plasminogen activation by joint action of the tissue plasminogen activator and a urokinase—Ffbrinogen conjugate

A. Maksimenko, E. G. Tishchenko, A. B. Dobrovol'skii, 1998, Pharmaceutical Chemistry Journal.

Effects of glycosaminoglycans in vascular events

A. Maksimenko, 2008, Pharmaceutical Chemistry Journal.

Conformational Transitions in 3D Model of Bovine Testicular Hyaluronidase during Molecular Docking with Glycosaminoglycan Ligands

A. Maksimenko, R. Beabealashvili, 2018, Russian Journal of Bioorganic Chemistry.

Effect of the hyaluronidase microe nvironment on the enzyme structure–function relationship and computational study of the in silico molecular docking of chondroitin sulfate and heparin short fragments to hyaluronidase

A. Maksimenko, R. Beabealashvili, 2018, Russian Chemical Bulletin.

Complex of papaya proteinases modified with soluble polymer and its possible medical application

V. Torchilin, A. Maksimenko, V. Abramova, 1989 .

Hyaluronidase Proof for Endothelial Glycocalyx as Partaker of Microcirculation Disturbances

A. Fedorovich, A. Rogoza, A. Maksimenko, 2013 .

Role of the Glycosaminoglycan Microenvironment of Hyaluronidase in Regulation of Its Endoglycosidase Activity

A. Maksimenko, E. Tischenko, Y. V. Schechilina, 2003, Biochemistry (Moscow).

Modified enzymes for pharmaceutical purposes. Extension of the goals and objectives for consistent investigation

A. Maksimenko, 2017, Russian Chemical Bulletin.

Widening and Elaboration of Consecutive Research into Therapeutic Antioxidant Enzyme Derivatives

A. Maksimenko, 2016, Oxidative medicine and cellular longevity.

Do electrostatic interactions determine glycation of hyaluronidase derivatives with N-acetylhexosamines?

A. Maksimenko, E. Tischenko, A. Turashev, 2012, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry.

[Antifibrotic effects of aldehyde dextran modified superoxide dismutase in experimental silicosis].

V. Torchilin, A. Maksimenko, E. G. Tishchenko, 1991, Biulleten' eksperimental'noi biologii i meditsiny.

Experimental combined thrombolytic therapy: The current position and directions of progress (review)

A. Maksimenko, 1994, Pharmaceutical Chemistry Journal.

Mutant and hybrid protein derivatives for the experimental therapy with plasminogen activators (review)

A. Maksimenko, 1994, Pharmaceutical Chemistry Journal.

Complicated Simplification of Dosage Regimen for Plasminogen Activators a

A. Maksimenko, 1996, Annals of the New York Academy of Sciences.

Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress

A. Maksimenko, A. Vavaev, 2012, Heart international.

The antioxidant and antiaggregant effects of the covalent bienzyme superoxide dismutase — Chondroitin sulfate — Catalase conjugate on platelets

A. Maksimenko, E. Tischenko, A. Vavaev, 2011 .

On Passage from Enzyme – Substrate to Receptor – Ligand Interactions in the Study of Urokinase Plasminogen Activators

A. Maksimenko, 2003, Pharmaceutical Chemistry Journal.

Experimentally Targeted Thrombolytic Therapy

A. Maksimenko, E. Tischenko, M. Smirnov, 1995 .

Fibrinogen‐immobilized Urokinase Demonstrates Increased Thrombolytic Activity in Animal Experiments

V. Torchilin, A. Maksimenko, E. Tischenko, 1990, Annals of the New York Academy of Sciences.

Water-soluble urokinase derivatives with increased affinity to the fibrin clot.

V. Torchilin, A. Maksimenko, 1985, Thrombosis research.

Immobilized Thrombolytic Enzymes Possessing Increased Affinity toward Substrate

V. Torchilin, A. Maksimenko, E. Tischenko, 1984, Annals of the New York Academy of Sciences.

Thrombolytic Effect after Sequential Double‐Bolus Administration of Tissue Plasminogen Activator and Urokinase‐Fibrinogen Conjugate into Dogs with Venous Thrombosis a

A. Maksimenko, E. Tischenko, V. L. Golubykh, 1998, Annals of the New York Academy of Sciences.

Conjunctive thrombolysis under the action of tissue-type plasminogen activator and conjugate urokinase-fibrinogen after double sequential bolus administration in the model of vein thrombosis in dogs

A. Dobrovolsky, A. Maksimenko, E. Tischenko, 1998 .

Translational research into vascular wall function: regulatory effects of systemic and specific factors

A. Maksimenko, 2017 .

Combined thrombolysis by joint action of the tissue plasminogen activator and A urokinase—fibrinogen conjugate upon sequential double bolus introduction in dogs with venous thrombosis model

A. Maksimenko, E. G. Tishchenko, A. B. Dobrovol'skii, 1998, Pharmaceutical Chemistry Journal.

Macromolecular Ensembles of External and Internal Fibrinolysis: Ways to Enhance the Thrombolytic Effect (A Review)

A. Maksimenko, 2002, Pharmaceutical Chemistry Journal.

Enzymatic Antioxidants: Next Phase of Pharmacological Effort to Fight Oxidative Stress?

A. Maksimenko, E. Tischenko, A. Vavaev, 2010 .

Selective killing of smooth muscle cells in culture by the ricin A-chain conjugated with monoclonal antibodies to a cell surface antigen via a dextran bridge

V. Torchilin, A. Tonevitsky, A. Faerman, 1985, Experientia.

Trypsin-like enzyme from Streptomyces 771. Purification and properties of native and immobilized enzyme.

V. Torchilin, A. Maksimenko, V. Smirnov, 1984, Applied biochemistry and biotechnology.

Thrombolysis research--new objectives after a shift of accent.

A. Maksimenko, 2002, Medical science monitor : international medical journal of experimental and clinical research.

[Endothelial glycocalyx of blood circulation. II. Biological functions, state at norm and pathology, bioengineering application].

A. Maksimenko, A. Turashev, 2014, Bioorganicheskaia khimiia.

Stratification of chondroitin sulfate binding sites in 3D-model of bovine testicular hyaluronidase and effective size of glycosaminoglycan coat of the modified protein

A. Maksimenko, R. Beabealashvili, A. Turashev, 2015, Biochemistry (Moscow).

Specific Effects of Chondroitin Sulfate-Modified Hyaluronidase on the Function of Progenitor Cells

A. V. Artamonov, A. Maksimenko, A. Dygai, 2014, Bulletin of Experimental Biology and Medicine.

Theoretical Research of Interactions Between Glycosidases and Glycosaminoglycan Ligands with Molecular Docking and Molecular Dynamics Methods

A. Maksimenko, 2020 .

Endothelial glycocalyx of blood circulation system. I. Detection, components, and structural organization

A. Maksimenko, A. Turashev, 2014, Russian Journal of Bioorganic Chemistry.

Endothelial glycocalyx of blood circulation system. II. Biological functions, state under normal and pathological conditions, and bioengineering applications

A. Maksimenko, A. Turashev, 2014, Russian Journal of Bioorganic Chemistry.

Immobilized enzymes for thrombolytic therapy.

V. Torchilin, A. Mazaev, A. Maksimenko, 1988, Methods in enzymology.

The principles of enzyme stabilization. III. The effect of the length of intra-molecular cross-linkages on thermostability of enzymes.

V. Torchilin, A. Klibanov, K. Martínek, 1978, Biochimica et biophysica acta.

Water-soluble urokinase derivatives of combined action.

V. Torchilin, A. Maksimenko, A. V. Maksimenko, 1985, Thrombosis research.

Potentiation and acceleration effects in combined administration of tissue plasminogen activator and fibrinogen-modified urokinase in dogs with modeled venous thrombosis

A. Maksimenko, E. G. Tishchenko, V. L. Golubykh, 2006, Bulletin of Experimental Biology and Medicine.

Venous thrombolysis by tissue-type plasminogen activator in conjunction with the urokinase-fibrinogen covalent conjugate

A. Maksimenko, E. Tischenko, A. D. Petrov, 1996, Applied biochemistry and biotechnology.

Effective Enzyme Thrombolytic Composition on the Basis of Wild‐type and Chemically Modified Plasminogen Activators a

A. Maksimenko, E. Tischenko, A. D. Petrov, 1996, Annals of the New York Academy of Sciences.

Fibrinolytic action of an enzyme preparation conjugated with specific antibodies

V. Torchilin, A. Maksimenko, E. G. Tishchenko, 1984, Bulletin of Experimental Biology and Medicine.

Catalase and chondroitin sulfate derivatives against thrombotic effect induced by reactive oxygen species in a rat artery.

A. Maksimenko, E. Tischenko, V. L. Golubykh, 2003, Metabolic engineering.

The combination of modified antioxidant enzymes for anti‐thrombotic protection of the vascular wall: the significance of covalent connection of superoxide dismutase and catalase activities

A. Maksimenko, E. Tischenko, Vladimir L. Golubykh, 2004, The Journal of pharmacy and pharmacology.

Extracellular oxidative damage of vascular walls and their protection using antioxidant enzymes

A. Maksimenko, 2007, Pharmaceutical Chemistry Journal.

Effect of Hydrogen Peroxide and Catalase Derivatives on Functional Activity of Platelets

A. Maksimenko, E. G. Tishchenko, L. Buryachkovskaya, 2012, Bulletin of Experimental Biology and Medicine.

Fibrinolytic action of an enzyme preparation covalently bound with modified thrombin

V. Torchilin, A. Maksimenko, A. N. Rusetskiĭ, 2004, Bulletin of Experimental Biology and Medicine.

Effect of Native and Modified Forms of Superoxide Dismutase and Catalase on Experimental Silicosis in Rats

V. Torchilin, A. Maksimenko, LJUDMILA M. Bezrukavnikova, 1992, Annals of the New York Academy of Sciences.

Biodistribution of a polyethylene glycol-modified superoxide dismutase in mice and its effect on myocardial ischemia treatment in rats

P. Caliceti, F. Veronese, A. Maksimenko, 1995 .

Results and Achievements in the Engineering of Pharmacological Enzymes for Clinical Application

A. Maksimenko, 2018 .

Approximation of new generation pharmacological enzyme researches to clinical practice

A. Maksimenko, 2022 .

[Antioxidant and antiaggregant effects of covalent bienzyme superoxide dismutase-chondroitin sulfate-catalase conjugate in platelet interactions].

A. Maksimenko, E. G. Tishchenko, A. Vavaev, 2012, Biomeditsinskaia khimiia.

Effect of Hydrogen Peroxide and Catalase Derivatives on Functional Activity of Platelets

A. Maksimenko, E. G. Tishchenko, L. Buryachkovskaya, 2012, Bulletin of Experimental Biology and Medicine.

[Protective action figurations for superoxide dismutase - chondroitin sulfate - catalase bienzyme conjugate after its medicative administration in endotoxin shock].

A. Timoshin, A. Maksimenko, V. Lakomkin, 2016, Biomeditsinskaia khimiia.

The principles of enzyme stabilization. IV. Modification of 'key' functional groups in the tertiary structure of proteins.

V. Torchilin, A. Klibanov, K. Martínek, 1979, Biochimica et biophysica acta.

Chemical modification of hyaluronidase as a means to regulate its inhibition by heparin

A. Maksimenko, E. G. Tishchenko, M. L. Petrova, 2000, Russian Journal of Bioorganic Chemistry.

Chemical modification of hyaluronidase regulates its inhibition by heparin.

A. Maksimenko, E. Tischenko, Y. V. Schechilina, 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Principles of enzyme stabilization. V. The possibility of enzyme selfstabilization under the action of potentially reversible intramolecular cross-linkages of different length.

V. Torchilin, K. Martínek, I. Berezin, 1979, Biochimica et biophysica acta.

Glycation of hyaluronidase by mono- and di-saccharides: Protective effect of chondroitin sulfate microenvironment in vitro and in silico

E. Nurminski, G. Likhatskaya, A. Maksimenko, 2008 .

Antifibrosis Effect of Enzyme Compositions (Superoxide Dismutase, Catalase, Hyaluronidase) in Experimental Silicosis

V. Torchilin, A. Maksimenko, E. Tischenko, 1992 .

In vitro andin vivo studies of native and dextran-modified hyaluronidase

V. Torchilin, A. Maksimenko, O. Arkhipova, 1986, Bulletin of Experimental Biology and Medicine.

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation

A. Maksimenko, A. Turashev, 2011, Biochemistry research international.

Endothelial glycocalyx as an orchestrator of vascular homeostasis. New research problems and prospects for vessel wall protection

A. Maksimenko, 2015, Russian Chemical Bulletin.

Optimization of reaction conditions during enzyme immobilization on soluble carboxyl-containing carriers

V. Torchilin, M. Papisov, A. Maksimenko, 1985 .

Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of superoxide dismutase and catalase.

A. Maksimenko, 2005, Current pharmaceutical design.

Conversion of Fibrinolysis Reserves into Thrombolysis Resources. Bolus Compositions of Plasminogen Activators

A. Maksimenko, 2021, Cardiology & Vascular Research.

[The modification of Cu, Zn-superoxide dismutase by monomethoxypolyethylene glycol improves the indices of the experimental therapy of the ischemic myocardium in rats].

P. Caliceti, F. Veronese, A. Maksimenko, 1993, Eksperimental'naia i klinicheskaia farmakologiia.